retatrutide type 2 diabetes phase 2 results a1c The next installment of the triple agonist is here with more top-line 3 results. TRANSCEND-T2D-1: Retatrutide in adults with obesity and diabetes. π Lowered of 1.7%β2.0% across New Kind of Diabetes Drug
Pay in 4 interest-free payments of $5.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 6 - Aug 11























